G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 2.4 GBX -2.04% Market Closed
Market Cap: 13m GBX
Have any thoughts about
Genedrive PLC?
Write Note

Genedrive PLC
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genedrive PLC
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
G
Genedrive PLC
LSE:GDR
Selling, General & Administrative
-ÂŁ1.4m
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
1%
Oxford Nanopore Technologies PLC
LSE:ONT
Selling, General & Administrative
-ÂŁ155.2m
CAGR 3-Years
-30%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Selling, General & Administrative
-ÂŁ22.8m
CAGR 3-Years
-32%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Selling, General & Administrative
-ÂŁ39.9m
CAGR 3-Years
-28%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Selling, General & Administrative
-ÂŁ4.4m
CAGR 3-Years
-19%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Selling, General & Administrative
-ÂŁ50.6m
CAGR 3-Years
-16%
CAGR 5-Years
-47%
CAGR 10-Years
-30%
No Stocks Found

Genedrive PLC
Glance View

Market Cap
13m GBX
Industry
Life Sciences Tools & Services

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

GDR Intrinsic Value
0.41 GBX
Overvaluation 83%
Intrinsic Value
Price
G

See Also

What is Genedrive PLC's Selling, General & Administrative?
Selling, General & Administrative
-1.4m GBP

Based on the financial report for Dec 31, 2023, Genedrive PLC's Selling, General & Administrative amounts to -1.4m GBP.

What is Genedrive PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
1%

Over the last year, the Selling, General & Administrative growth was 17%. The average annual Selling, General & Administrative growth rates for Genedrive PLC have been 13% over the past three years , 15% over the past five years , and 1% over the past ten years .

Back to Top